Beximco Pharmaceuticals's total inventories for the quarter that ended in Dec. 2024 was $122.81 Mil. Beximco Pharmaceuticals's average total inventories from the quarter that ended in Sep. 2024 to the quarter that ended in Dec. 2024 was $118.93 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Beximco Pharmaceuticals's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was $-0.20.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Beximco Pharmaceuticals's Days Inventory for the
three
months ended in Dec. 2024 was 198.28.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Beximco Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.46.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Beximco Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 1.19.
Beximco Pharmaceuticals (OTCPK:BXMPY) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Beximco Pharmaceuticals's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Beximco Pharmaceuticals's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Beximco Pharmaceuticals Total Inventories Related Terms
Beximco Pharmaceuticals Total Inventories Historical Data
* Premium members only.
The historical data trend for Beximco Pharmaceuticals's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beximco Pharmaceuticals Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
What does a Total Inventories of $122.81 Mil mean?
Beximco Pharmaceuticals (BXMPY) has a Total Inventories of $122.81 Mil as of Dec. 2024. The total amount of inventory as recorded on a company's balance sheet. View historical data for Beximco Pharmaceuticals and its competitors.
Is Beximco Pharmaceuticals' Total Inventories too high?
Beximco Pharmaceuticals' current Total Inventories is $122.81 Mil. Overall, Beximco Pharmaceuticals has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Beximco Pharmaceuticals' Total Inventories compare to ZTS and UTHR?
Beximco Pharmaceuticals' Total Inventories of $122.81 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Drug Manufacturers company?
A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Beximco Pharmaceuticals and its competitors. Beximco Pharmaceuticals's current Total Inventories is $122.81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beximco Pharmaceuticals stock overvalued right now?
Beximco Pharmaceuticals (BXMPY) has a current Total Inventories of $122.81 Mil. The current Total Inventories is $122.81 Mil. Beximco Pharmaceuticals' overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Beximco Pharmaceuticals (BXMPY), the current Total Inventories is $122.81 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Beximco Pharmaceuticals PLC is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from domestic sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BXMPY has been successfully added to your 